Recommendations for Addressing Harm–Benefit Analysis and Implementation in Ethical Evaluation – Report from the AALAS–FELASA Working Group on Harm–Benefit Analysis – Part 2

International regulations and guidelines strongly suggest that the use of animal models in scientific research should be initiated only after the authority responsible for the review of animal studies has concluded a well-thought-out harm–benefit analysis (HBA) and deemed the project to be appropria...

Descripción completa

Detalles Bibliográficos
Autores principales: Laber, Kathy, Newcomer, Christian E, Decelle, Thierry, Everitt, Jeffrey I, Guillen, Javier, Brønstad, Aurora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Working Party Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815834/
https://www.ncbi.nlm.nih.gov/pubmed/27188276
http://dx.doi.org/10.1177/0023677216642397
_version_ 1783300579185917952
author Laber, Kathy
Newcomer, Christian E
Decelle, Thierry
Everitt, Jeffrey I
Guillen, Javier
Brønstad, Aurora
author_facet Laber, Kathy
Newcomer, Christian E
Decelle, Thierry
Everitt, Jeffrey I
Guillen, Javier
Brønstad, Aurora
author_sort Laber, Kathy
collection PubMed
description International regulations and guidelines strongly suggest that the use of animal models in scientific research should be initiated only after the authority responsible for the review of animal studies has concluded a well-thought-out harm–benefit analysis (HBA) and deemed the project to be appropriate. The AALAS–FELASA working group on HBA has performed a literature review and based on this review, proposed a method for HBA. Examples of the working group’s approach are included in this report.
format Online
Article
Text
id pubmed-5815834
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-58158342018-02-16 Recommendations for Addressing Harm–Benefit Analysis and Implementation in Ethical Evaluation – Report from the AALAS–FELASA Working Group on Harm–Benefit Analysis – Part 2 Laber, Kathy Newcomer, Christian E Decelle, Thierry Everitt, Jeffrey I Guillen, Javier Brønstad, Aurora Lab Anim Working Party Report International regulations and guidelines strongly suggest that the use of animal models in scientific research should be initiated only after the authority responsible for the review of animal studies has concluded a well-thought-out harm–benefit analysis (HBA) and deemed the project to be appropriate. The AALAS–FELASA working group on HBA has performed a literature review and based on this review, proposed a method for HBA. Examples of the working group’s approach are included in this report. SAGE Publications 2016-05-17 2016-06 /pmc/articles/PMC5815834/ /pubmed/27188276 http://dx.doi.org/10.1177/0023677216642397 Text en © The Author(s) 2016 http://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution 4.0 License (http://www.creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Working Party Report
Laber, Kathy
Newcomer, Christian E
Decelle, Thierry
Everitt, Jeffrey I
Guillen, Javier
Brønstad, Aurora
Recommendations for Addressing Harm–Benefit Analysis and Implementation in Ethical Evaluation – Report from the AALAS–FELASA Working Group on Harm–Benefit Analysis – Part 2
title Recommendations for Addressing Harm–Benefit Analysis and Implementation in Ethical Evaluation – Report from the AALAS–FELASA Working Group on Harm–Benefit Analysis – Part 2
title_full Recommendations for Addressing Harm–Benefit Analysis and Implementation in Ethical Evaluation – Report from the AALAS–FELASA Working Group on Harm–Benefit Analysis – Part 2
title_fullStr Recommendations for Addressing Harm–Benefit Analysis and Implementation in Ethical Evaluation – Report from the AALAS–FELASA Working Group on Harm–Benefit Analysis – Part 2
title_full_unstemmed Recommendations for Addressing Harm–Benefit Analysis and Implementation in Ethical Evaluation – Report from the AALAS–FELASA Working Group on Harm–Benefit Analysis – Part 2
title_short Recommendations for Addressing Harm–Benefit Analysis and Implementation in Ethical Evaluation – Report from the AALAS–FELASA Working Group on Harm–Benefit Analysis – Part 2
title_sort recommendations for addressing harm–benefit analysis and implementation in ethical evaluation – report from the aalas–felasa working group on harm–benefit analysis – part 2
topic Working Party Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815834/
https://www.ncbi.nlm.nih.gov/pubmed/27188276
http://dx.doi.org/10.1177/0023677216642397
work_keys_str_mv AT laberkathy recommendationsforaddressingharmbenefitanalysisandimplementationinethicalevaluationreportfromtheaalasfelasaworkinggrouponharmbenefitanalysispart2
AT newcomerchristiane recommendationsforaddressingharmbenefitanalysisandimplementationinethicalevaluationreportfromtheaalasfelasaworkinggrouponharmbenefitanalysispart2
AT decellethierry recommendationsforaddressingharmbenefitanalysisandimplementationinethicalevaluationreportfromtheaalasfelasaworkinggrouponharmbenefitanalysispart2
AT everittjeffreyi recommendationsforaddressingharmbenefitanalysisandimplementationinethicalevaluationreportfromtheaalasfelasaworkinggrouponharmbenefitanalysispart2
AT guillenjavier recommendationsforaddressingharmbenefitanalysisandimplementationinethicalevaluationreportfromtheaalasfelasaworkinggrouponharmbenefitanalysispart2
AT brønstadaurora recommendationsforaddressingharmbenefitanalysisandimplementationinethicalevaluationreportfromtheaalasfelasaworkinggrouponharmbenefitanalysispart2

Ejemplares similares